Organigram (OGI)

Search documents
Organigram (OGI) - 2022 Q1 - Earnings Call Presentation
2022-01-11 14:06
ORGANIGRAM INVESTOR PRESENTATION Q1 FISCAL 2022 LORGANIGRAM NASDAQ (OGI) TSX (OGI) CAUTIONARY STATEMENT This document is current as of January 11, 2022, except where otherwise stated. The information contained in this presentation is provided by Organigram Holdings Inc. ("Organigram" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of Organigram or other financial products. No part of this pr ...
Organigram (OGI) - 2021 Q4 - Earnings Call Transcript
2021-11-23 17:22
OrganiGram Holdings Inc. (NASDAQ:OGI) Q4 2021 Earnings Conference Call November 23, 2021 8:00 AM ET Company Participants | --- | |-----------------------------------------------------------------------------------| | | | | | Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer | | Conference Call Participants | | Frederico Gomes - ATB | | Rahul Sarugaser - Raymond James | | Rupesh Parikh - Oppenheimer | | | | Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets ...
Organigram (OGI) - 2021 Q4 - Earnings Call Presentation
2021-11-23 14:02
ORGANIGRAM INVESTOR PRESENTATION (UPDATED: Q4 FISCAL 2021) NASDAQ (OGI) TSX (OGI) CORGANIGRAM CAUTIONARY STATEMENT This document is current as of November 22, 2021, except where otherwise stated. The information contained in this presentation is provided by Organigram ("OGI" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of OGI or other financial products. No part of this presentation shall ...
Organigram (OGI) - 2021 Q3 - Earnings Call Transcript
2021-07-13 17:31
OrganiGram Holdings Inc. (NASDAQ:OGI) Q3 2021 Earnings Conference Call July 13, 2021 8:00 AM ET Company Participants Amy Schwalm - Vice President, Investor Relations Derrick West - Chief Financial Officer Paolo De Luca - Chief Strategy Officer Conference Call Participants David Kideckel - ATB Capital Markets Andrew Partheniou - Stifel GMP Tamy Chen - BMO Capital Markets Adam Buckham - Scotiabank Rupesh Parikh - Oppenheimer John Zamparo - CIBC Operator Good morning. My name is Renz and I will be your operato ...
OrganiGram Holdings (OGI) Investor Presentation - Slideshow
2021-06-16 19:02
ORGANIGRAM INVESTOR PRESENTATION NASDAQ (OGI) TSX (OGI) L ORGANIGRAM CAUTIONARY STATEMENT This document is current as of June 6, 2021, except where otherwise stated. The information contained in this presentation is provided by Organigram ("OGI" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of OGI or other financial products. No part of this presentation shall form the basis or be relied u ...
Organigram (OGI) - 2021 Q2 - Earnings Call Transcript
2021-04-13 18:33
OrganiGram Holdings Inc. (NASDAQ:OGI) Q2 2021 Earnings Conference Call April 13, 2021 8:00 AM ET Company Participants Amy Schwalm - Vice President, Investor Relations Greg Engel - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Andrew Partheniou - Stifel David Kideckel - ATB Capital Markets Tamy Chen - BMO John Zamparo - CIBC Madeleine Stone - Oppenheimer Aaron Grey - Alliance Global Partners Graeme Kindler - Eight Capital Rahul Sarugaser - Raymond James Douglas M ...
Organigram (OGI) - 2021 Q2 - Earnings Call Presentation
2021-04-13 14:47
ORGANIGRAM Q2 FISCAL 2021 RESULTS APRIL 13, 2021 NASDAQ (OGI) TSX (OGI) CORGANIGRAM CAUTIONARY STATEMENT This document is current as of April 13, 2021, except where otherwise stated. The information contained in this presentation is provided by Organigram ("OGI" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of OGI or other financial products. No part of this presentation shall form the bas ...
Organigram (OGI) - 2021 Q1 - Earnings Call Transcript
2021-01-12 18:22
Financial Data and Key Metrics Changes - In Q1 2021, Canadian adult use recreational net revenue grew 30% to CAD 16.8 million from CAD 12.9 million in the prior year quarter, while gross recreational revenue grew 42% to CAD 22.5 million from CAD 15.9 million [42] - Total net revenue for Q1 2021 was CAD 19.3 million, down from CAD 25.2 million in the prior-year quarter, primarily due to lower wholesale revenue and a lower average selling price [43] - The net loss for Q1 2021 was CAD 34.3 million or CAD 0.17 per share, compared to a net loss of CAD 0.9 million or CAD 0.01 per share in the prior-year quarter [48] Business Line Data and Key Metrics Changes - The company launched 53 new SKUs since July, with 14 more expected to launch before the end of February [10] - Sales of the SHRED product significantly contributed to growth in recreational revenue in Q1, becoming the most searched brand on the Ontario cannabis store website for November and December [21] - The Edison flower portfolio is focused on higher margin products, with new strains launched that have THC ranges of 20% to 26% [12] Market Data and Key Metrics Changes - The Canadian recreational cannabis market is estimated at CAD 3.2 billion, with a significant driver being the increase in the number of retail stores, particularly in Ontario [50] - The number of cannabis retail stores in Ontario grew by approximately 47% to 1,414 stores as of early January 2021 [51] - The recreational cannabis beverage market in Canada represents a potential CAD 467 million opportunity, with a significant majority of consumers preferring to add cannabis to their beverages [27] Company Strategy and Development Direction - The company is focused on revitalizing its product portfolio and has plans to introduce new products under the Edison brand [8] - There is an emphasis on higher margin products and scaling up cultivation and staffing to meet increased demand [32] - The company is exploring opportunities in the U.S. market, particularly in CBD, but has not yet found suitable partners [86] Management's Comments on Operating Environment and Future Outlook - Management acknowledged potential dampening of industry demand due to COVID-19 lockdowns affecting retail sales in Ontario [34] - The company is optimistic about future growth opportunities as it ramps up staffing and production to meet market demand [32] - Management highlighted the importance of maintaining inventory levels to avoid being delisted from retail listings [103] Other Important Information - The company ended the quarter with CAD 134 million in cash and short-term investments, and after paying down a term loan, had a pro forma cash balance of CAD 79 million [39] - The company is investing in automation to drive cost efficiencies and reduce reliance on manual labor [37] - The introduction of a new pre-roll machine is expected to significantly reduce labor costs and increase production efficiency [94] Q&A Session Summary Question: Comments on gross margin profile and product mix - Management indicated that dried flower makes up the greatest proportion of revenue, with a shift towards higher margin Edison products expected to improve gross margins over time [64] Question: Seasonality effects in December - Management noted good responses to seasonal offerings but observed lower revenue in disposable vape pens due to COVID-19 impacts [72] Question: Unabsorbed costs and production utilization - Unabsorbed overhead fixed costs were CAD 2.7 million due to operating at approximately 40% capacity, with expectations for improvement as staffing increases [77] Question: Balance sheet and capitalization levels - Management expressed comfort with the balance sheet, highlighting CAD 79 million in cash and short-term investments after debt repayment [107] Question: Gross margin recovery expectations - Management indicated that achieving previous gross margin levels would depend on reaching higher net cannabis revenue, potentially around CAD 25 million [108]
Organigram (OGI) - 2020 Q4 - Earnings Call Transcript
2020-11-30 19:07
OrganiGram Holdings Inc. (NASDAQ:OGI) Q4 2020 Earnings Conference Call November 30, 2020 8:00 AM ET Company Participants Amy Schwalm - Investor Relations Greg Engel - Chief Executive Officer Derrick West - Chief Financial Officer Paolo de Luca - Chief Strategy Officer Conference Call Participants Aaron Grey - Alliance Global Partners David Kideckel - ATB Capital Markets. Andrew Partheniou - Stifel Nicolaus Canada Inc. Adam Buckham - Scotiabank, Inc. Graeme Kreindler - Eight Capital Rupesh Parikh - Oppenheim ...
Organigram (OGI) - 2020 Q3 - Earnings Call Transcript
2020-07-21 18:45
OrganiGram Holdings Inc. (NASDAQ:OGI) Q3 2020 Earnings Conference Call July 21, 2020 8:00 AM ET Company Participants | --- | |----------------------------------------| | | | Amy Schwalm - Investor Relations | | Greg Engel - Chief Executive Officer | | Derrick West - Chief Financial Officer | | Paolo de Luca - Chief Strategy Officer | | Conference Call Participants | | Aaron Grey - Alliance Global Partners | | Andrew Partheniou - Stifel GMP | | Tamy Chen - BMO Capital Markets | | Adam Buckham - Scotiabank | ...